The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
Sigma Lithium Corporation
SGML · Nasdaq · USD · Market cap $916M · 560 employees
Sigma Lithium Corporation engages in the exploration and development of lithium deposits in Brazil.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price5.15 USD at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.52x the price, above our 1.35x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 474.57)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 474.57, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Sigma Lithium Corporation holds its Distribution at $5.15. Elevated stress, defensive posture warranted, held for 4 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 4 days |
| Price at the screen | $5.15 |
| Valuation | N/A trailing · 4.44 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.68 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 48.79% | Below 33% | Interest-bearing debt is 48.8% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 2.59% | Below 49% | Money owed to the company is 2.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 2.02% | Below 5% | Only 2.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Sigma Lithium's business is in a permissible area, but its interest-bearing debt is about 49% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SGML's ethical verdict changes
Today SGML does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.52x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 3 covering, consensus Buy. The average target sits +114% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLithium miner valuation ignores the cycle swings
Picture an EV battery boom that suddenly cools. Orders slow, prices drop and a Brazilian lithium developer with no profits yet feels the squeeze hard. Sigma Lithium shows a forward multiple of just 6.1 times, yet revenue is already falling 11 percent and margins sit at minus 42 percent, so the cheap reading is mostly an illusion created by peak-cycle thinking.
We pass because this is a classic cyclical value trap. The low multiple and 35 percent gap to our fair value number look tempting on a screen, yet negative 49 percent ROE and an unknown moat tell us earnings are fragile and tied to commodity swings rather than durable demand. Two analysts see a much higher target, but history shows these forecasts often collapse when battery makers cut purchases.
Risk sits in the commodity price and funding exposure that can wipe out thin balance sheets quickly. Ethical screen clears, yet the numbers still flag a business that needs sustained high lithium prices to justify any ownership. Analysis, not advice.
| Forward P/E | 4.4xcheap for a company growing this fast |
| EPS, trailing | -0.24 |
| EPS, forward | 1.83 |
| Revenue growth | +223.9%growing very fast |
| Profit margin | -19.3%currently unprofitable |
| Return on equity | -31.6%not currently earning a positive return on equity |
| FCF yield | 4.81% |
| Debt to equity | 3.37heavy leverage: higher risk if revenue softens |
| Current ratio | 0.34below 1: short-term bills exceed liquid assets |
| Beta | 0.68steadier than the market |
| Short interest, float | 0.08% |
| 52-week range | 4.62 - 24.48 |
| Market cap | $916M |
| Employees | 560 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Canada and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSGML trades on Nasdaq (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 32.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 39% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 39% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 22.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 39% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 35.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 39% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 39% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 129%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it strong buy, with a mean price target of $21.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Sigma Lithium Corporation (SGML) Stock Dips While Market Gains: Key Facts Yahoo Finance · 9 Oct 2026
- Implied Volatility Surging for Sigma Lithium Stock Options Yahoo Finance · 9 Oct 2026
- Sigma Lithium (SGML) Following License Reinstatement Still Looks Undervalued On One View Yahoo Finance · 8 Oct 2026
- Sigma Lithium resumes Brazil operations after appeals court upholds environmental licences Yahoo Finance · 7 Oct 2026
- Premarket movers: Constellation Brands tumbles, SpaceX debt plans weigh Yahoo Finance · 7 Oct 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $20.30 | -36.0% | · | $640 | -36.0% |
| 2 months | $14.85 | -12.5% | · | $875 | -12.5% |
| 3 months | $11.94 | +8.8% | · | $1,088 | +8.8% |
| 6 months | $11.70 | +11.0% | · | $1,110 | +11.0% |
| 1 year | $5.68 | +128.7% | · | $2,287 | +128.7% |
| 2 years | $13.99 | -7.2% | · | $929 | -7.2% |
| 3 years | $41.78 | -68.9% | · | $311 | -68.9% |
| 5 years | $4.94 | +163.0% | · | $2,630 | +163.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SGML does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.